Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-24-035576

Options or other derivatives

  • Chief Business Officer acquired 323,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McKinley Kate Chief Business Officer 2024-03-21 Grant or award · Stock Option (Right to Buy) +323,500 323,500 D
Loading xslF345X05/ownership.xml…